Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies.

ABSTRACT: Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.

SUBMITTER: Staal DP 

PROVIDER: S-EPMC11340011 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature